Safety Study of Immune System Modulator for Autoimmune Diseases

NCT02243683 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Artax Biopharma Inc

Collaborators